RojgarSetu RojgarSetu

यह लेख हिंदी में भी उपलब्ध है —

हिंदी में पढ़ें
Government Schemes 22 September 2026 · Event date: 21 September 2026
EN हिं

Union MoS for Health and Family Welfare Smt. Anupriya Patel launches 7th National Formulary of India 2026, announces Biovigilance Programme to widen India’s patient-safety net

Union MoS for Health and Family Welfare Smt. Anupriya Patel launches 7th National Formulary of India 2026, announces Biovigilance Programme to widen India’s patient-safety net
Official visual from the source release · Source: Press Information Bureau

Union Minister of State Smt. Anupriya Patel launched the 7th Edition of the National Formulary of India (NFI) 2026, the Guidance Document for Hospitals on medical device safety, and the ADR-PvPI 2.0 Mobile App for iOS users. She also announced the government approval of the Biovigilance Programme of India during the 6th National Pharmacovigilance Week. India's global ranking in contributions to the WHO patient safety database has risen to 8th position.

In Simple Words

Union Minister of State Smt. Anupriya Patel launched the 7th Edition of the National Formulary of India (NFI) 2026, along with safety guidelines for hospitals and the ADR-PvPI 2.0 Mobile App for iOS users, during the 6th National Pharmacovigilance Week. She also announced the approval of the Biovigilance Programme of India to monitor adverse events related to biological products in organ and tissue transplantation.

India has advanced from the 123rd position to 8th globally in contributions to the WHO patient safety database. The newly launched NFI 2026 features 34 chapters, 20 appendices, and 653 drugs. Additionally, digital platforms like NFI Online and approximately 1,150 adverse drug reaction reporting centres are helping strengthen medicine safety and patient care across the country.

Key Points

  • Smt. Anupriya Patel launched the 7th Edition of the National Formulary of India (NFI) 2026.
  • The 6th National Pharmacovigilance Week is observed from 17-23 September 2026.
  • The theme for the 6th National Pharmacovigilance Week is "Promoting Rational Use of Medicines through Pharmacovigilance: A Step Towards Safer Healthcare."
  • India rose from the 123rd position during 2009-2014 to 8th globally in contributions to the WHO patient safety database.
  • The Government of India approved the Biovigilance Programme of India.
  • The NFI 2026 comprises 34 chapters, 20 appendices, and 653 drugs, including 42 fixed-dose combinations and 30 immunologicals.
  • Around 25 countries recognize and accept the Indian Pharmacopoeia.
  • There are approximately 1,150 operational ADR reporting centres across public and private hospitals, medical colleges, and medical-device vigilance facilities in the country.

Exam Angle

Minister launching NFI 2026
Smt. Anupriya Patel
Global rank in WHO patient safety database contributions
8th
Chapters in NFI 2026
34
Drugs included in NFI 2026
653

A. 7th Edition

Source: Press Information Bureau

Related Current Affairs

Appeal to Employees of Public Sector Banks and Regional Rural Banks for Ensuring Uninterrupted Banking Services The Government has appealed to employees of Public Sector Banks and Regional Rural Banks to ensure uninterrupted banking services and refrain from proposed strikes. While unions called for strikes over five-day banking and the Performance Linked Incentive scheme, the Government has already kept the PLI scheme in abeyance and highlighted numerous welfare measures taken for bank employees. Prime Minister congratulates Rudrankksh Balasaheb Patil for winning a Bronze Medal at the Asian Games Prime Minister Shri Narendra Modi has congratulated Rudrankksh Balasaheb Patil for winning a bronze medal at the Asian Games. The Prime Minister praised Patil's focus and discipline throughout the event and wished him the best for his future endeavours. Sowa-Rigpa Working Group Holds First Meeting Under PCIM&H The Pharmacopoeia Commission for Indian Medicine Homoeopathy hosted the first meeting of the Sowa-Rigpa Working Group in Ghaziabad, Uttar Pradesh. Chaired by Dr. Kousthubha Upadhyaya, the meeting focused on developing Sowa-Rigpa Pharmacopoeias, Formularies, and quality assurance standards under the Drugs and Cosmetics Act, 1940. This initiative aims to standardise traditional medicines within the Indian government's regulatory framework. Vice-President calls for modernising tea industry, strengthening research and building Indian tea brands for global markets Vice-President Shri C. P. Radhakrishnan inaugurated the Centenary Conference of the UPASI Tea Research Foundation at Coonoor. He emphasized modernising the tea industry, strengthening research, improving quality, and building strong Indian tea brands for global markets.

Keep Preparing